Complementary and Alternative Therapies for Genitourinary Syndrome of Menopause : An Evidence Map
Authors' conclusion
There is a large and heterogeneous literature of CAM interventions for GSM. Trials were small, and few were done in North America. Standardized population, intervention, comparator, and outcomes reporting in future RCTs are needed.
Study context
- Population
- Postmenopausal women with genitourinary syndrome of menopause (GSM); Randomized controlled trials (RCTs) ≥8 weeks with ≥20 participants randomly assigned per group57 trials
- Comparison
- Complementary and alternative medicine or therapies for GSM
- Outcome
- Evidence map of CAM trials for GSM
Methodological detailsevidence map approach, narrative summaries, English-language studies only, Data abstracted by 1 reviewer and verified by a second, Ovid MEDLINE, EMBASE and CINAHL searched from inception through 11 December 2023
- Evidence map approach
- Narrative summaries
- English-language studies only
- Data abstracted by 1 reviewer and verified by a second
- Ovid MEDLINE, EMBASE and CINAHL searched from inception through 11 December 2023
Pooled result
As reported in the abstract
- Trials identified
- 57
- Unique interventions investigated
- 39
- Studies typically small
- n < 200
- Trials done in Iran
- k = 24
- Trials done in other parts of Asia
- k = 9
- Trials of natural products (herbal or botanical supplements and vitamins)
- k = 44
- Trials of mind and body practices
- k = 6
- Trials of educational programs
- k = 7
- Trials reporting sexual symptoms
- k = 44
- Trials reporting vulvovaginal symptoms
- k = 30
Safety
- Trials reporting on adverse events
- k = 33
Original publication
Complementary and Alternative Therapies for Genitourinary Syndrome of Menopause : An Evidence Map. Ann Intern Med. Published 10 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →